Rescriptor Oral Tablet 100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Rescriptor: Oral tablet (100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_4670.JPG
Rescriptor 100mg Tab
Pfizer Inc.
Pill Identification: U 3761 
Drug Image file DrugItem_12733.JPG
Rescriptor 100mg Tab
Agouron Pharmaceuticals Inc, a subsidiary of Pfizer
Pill Identification: U 3761 
Drug Image file DrugItem_2910.JPG
Rescriptor 100mg Tab
Agouron Pharmaceuticals Inc, a subsidiary of Pfizer
Pill Identification: U 3761 

What is this Medicine?

DELAVIRDINE (de la VIR deen) is an antiretroviral medicine. It is used with other medicines to treat HIV. This medicine is not a cure for HIV. It will not stop the spread of HIV to others.

In-Depth Information
Select a Medication

Rescriptor 100mg Tablet

NDC: 497020209
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Human Immunodeficiency Virus (HIV) Infection

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Rescriptor 100mg Tablet

Reported Side Effects for Rescriptor 100mg Tablet

Breakdown Of Muscle Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Kidney Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Liver Failure Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hemolytic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Increased Blood Sugar Incidence:
0.8-1.7%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sugar Incidence:
0.8-1.7%*
Severity: MODERATE
Onset: EARLY
Sinus Infection Incidence:
1.2-7.3%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
1.2-7.6%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
1.2-5.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
1.6-7.1%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
1.6-5.0%*
Severity: MILD
Onset: DELAYED
High Bilirubin Level Incidence:
1.7-2.5%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.8-5.1%*
Severity: MODERATE
Onset: DELAYED
Flu Incidence:
2.4-7.3%*
Severity: MILD
Onset: DELAYED
Nervousness Incidence:
2.4-6.7%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
2.4-5.9%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
2.4-5.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
2.5-6.5%*
Severity: MILD
Onset: EARLY
High Amylase Levels Incidence:
2.5-2.9%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
3.5-5.0%*
Severity: MILD
Onset: DELAYED
Skin Ulcer Incidence:
4.4%*
Severity: MODERATE
Onset: DELAYED
Vesicular Rash Incidence:
4.4%*
Severity: MILD
Onset: DELAYED
Depression Incidence:
4.9-12.6%*
Severity: MODERATE
Onset: DELAYED
Weakness Incidence:
5.3-16.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
5.3-16.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
11.2-16.8%*
Severity: MILD
Onset: EARLY
Rash With Pustules Incidence:
14.3%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
14.7-20.3%*
Severity: MILD
Onset: EARLY
Itching Incidence:
16.7%*
Severity: MILD
Onset: RAPID
Skin Redness Incidence:
16.7%*
Severity: MODERATE
Onset: EARLY
Skin Rash Incidence:
35.4%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Rescriptor 100mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Marijuana and Rescriptor 100mg Tablet(Delavirdine Mesylate)
Marijuana and Non-nucleoside reverse transcriptase inhibitors(Delavirdine Mesylate)
Although an interaction is possible, these drugs may be used together. In therory, side effects from Marijuana, Medical may get worse if you take Anti-retroviral non-nucleoside reverse transcriptase inhibitors (NNRTIs). However, the importance of this interaction is not known. Notify your health care provider if you notice increased fatigue, nausea, vomiting, or any other unusual effects.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Rescriptor

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5